Bratica Joseph 4
4 · Sarepta Therapeutics, Inc. · Filed Dec 10, 2020
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-08$29.60/sh+1,125$33,300→ 9,265 total - Sale
Common Stock
2020-12-08$160.00/sh−1,125$180,000→ 8,140 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-08−1,125→ 4,500 totalExercise: $29.60From: 2018-03-31Exp: 2027-03-31→ Common Stock (1,125 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
- [F2]Amount of Securities Beneficially Owned includes 308 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2020.